共 199 条
[1]
Beck AT(1996)Comparison of Beck depression inventories -IA and -II in psychiatric outpatients J Pers Assess 67 588-597
[2]
Steer RA(2019)The impact of (the concept of) treatment-resistant depression: an opinion review Int J Neuropsychopharmacol 22 85-92
[3]
Ball R(2014)Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression Biol Psychiatry 76 176-185
[4]
Ranieri W(2020)Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) report Neuropsychopharmacology 45 1390-1397
[5]
Demyttenaere K(2009)Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats Prog Neuro-Psychopharmacol Biol Psychiatry 33 450-455
[6]
Van Duppen Z(1960)A rating scale for depression J Neurol Neurosurg Psychiatry 23 56-62
[7]
Downar J(2016)Combining clinical variables to optimize prediction of antidepressant treatment outcomes J Psychiatr Res 78 94-102
[8]
Geraci J(2020)Neurobiological biomarkers of response to ketamine Adv Pharmacol 89 195-235
[9]
Salomons TV(2013)Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond Biol Psychiatry 73 1133-1141
[10]
Dunlop K(2014)Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression Transl Psychiatry 4 e469-2098